GSK - Pharmaceutical Company.

HideShow resource information
What is Glaxosmithline?
major pharmaceutical company headquartered in the UK with a 2013 turnover of £23 billion, global operations 84 manufacturing sites in 36 different countries and large research and development (R&D) centres in the UK, USA, Spain, Belgium and China.
1 of 6
Development and Distribution of products (1/2)
Distribution of over 800m doses of vaccine in 2014, 80% to developing countries. Other important areas of operation include medications for type-2 diabetes, bacterial infection and oncology with many drugs on WHO’s list of essential medications.
2 of 6
Issues with LIDCS (1/2)
A problem that they face is that demand for new drugs in LIDCs, whose economies are weak, is often too small to recoup development costs despite being urgently needed for huge benefits. Therefore GSK devotes significant R&D resources to LIDC needs.
3 of 6
Issues with LIDCS (2/2)
Research centre in Spain focuses primarily on TB, malaria and other tropical diseases; they are also close to launching the first effective vaccine against malaria as well as develop an Ebola vaccine.
4 of 6
What is part of the company's ethical policy towards the developing world?
5% returns on each product sold. Providing HIV/AIDS drugs to LIDCs discounted. Licensing of cheap generic versions of patented drugs. Capping patented drug prices to 25% of UK prices. Investing 20% of its profits from sales in LIDCs in healthcare.
5 of 6
Development and Distribution of products (2/2)
GSK employs 13,000 people in R&D and spends over £3 billion a year researching new medicines. Usually undertaken with companies/universities/research charities. GSK is currently researching for HIV/AIDS, malaria and TB which is costly/unsuccessful.
6 of 6

Other cards in this set

Card 2

Front

Development and Distribution of products (1/2)

Back

Distribution of over 800m doses of vaccine in 2014, 80% to developing countries. Other important areas of operation include medications for type-2 diabetes, bacterial infection and oncology with many drugs on WHO’s list of essential medications.

Card 3

Front

Issues with LIDCS (1/2)

Back

Preview of the front of card 3

Card 4

Front

Issues with LIDCS (2/2)

Back

Preview of the front of card 4

Card 5

Front

What is part of the company's ethical policy towards the developing world?

Back

Preview of the front of card 5
View more cards

Comments

No comments have yet been made

Similar Geography resources:

See all Geography resources »See all Case studies resources »